This study was funded by a Canadian Institutes of Health Research (CIHR) Knowledge Synthesis grant to J.L.S., R.J.D., A.M., A.J.C., J.B., M.D., A.L.J., L.A.L., T.M.S.W., C.W.C.K. and D.J.A.J. and an unrestricted grant from the Calorie Control Council to J.L.S., R.J.D., J.B., C.W.C.K. and D.J.A.J. J. L. S. was supported by a Province of Ontario Postdoctoral Fellowship, the Edie Steinberg Scholarship Fund and the Edward Christie Stevens Fellowship in Medicine. R.J.D. was funded by a CIHR Postdoctoral Fellowship Award and A.M. was funded by a CIHR Canada Graduate Scholarship Master's award. D. J. A. J. was funded by the Government of Canada through the Canada Research Chair Endowment. None of the sponsors had a role in any aspect of the present study, including design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript. J. L. S. has received several unrestricted travel grants to present research at meetings from The Coca-Cola Company and is a co-investigator on an unrestricted research grant from The Coca-Cola Company. J. L. S. has also received travel funding and honoraria from the Archer Daniels Midland, International Life Sciences Institute (ILSI) North America and Abbott Laboratories; and research support, consultant fees and travel funding from Pulse Canada. R. J. d. S, J. B. and C. W. C. K. are co-investigators on an unrestricted grant from The Coca-Cola Company. C. W. C. K. has served on the scientific advisory board, received research support, travel funding, consultant fees, or honoraria from Pulse Canada, Barilla, Solae, Unilever, Hain Celestial, Loblaws, Inc., Oldways Preservation Trust, the Almond Board of California, the International Nut Council, Paramount Farms, the California Strawberry Commission, the Canola and Flax Councils of Canada, and Saskatchewan Pulse Growers. C. W. C. K. also receives partial salary funding from research grants provided by Unilever, Loblaw's and the Almond Board of California. D. J. A. J. holds an unrestricted grant from The Coca-Cola Company and has served on the scientific advisory board for or received research support, consultant fees or honoraria from Barilla, Solae, Unilever, Hain Celestial, Loblaws Supermarkets, Inc., Sanitarium Company, Herbalife International, Pacific Health Laboratories, Inc., Metagenics/MetaProteomics, Bayer Consumer Care, Oldways Preservation Trust, The International Tree Nut Council Nutrition Research & Education, The Peanut Institute, Procter and Gamble Technical Centre Limited, Griffin Hospital for the development of the NuVal System, Soy Advisory Board of Dean Foods, Alpro Soy Foundation, Nutritional Fundamentals for Health, Pacific Health Laboratories, Kellogg's, Quaker Oats, The Coca-Cola Sugar Advisory Board, Pepsi Company, Agrifoods and Agriculture Canada (AAFC), Canadian Agriculture Policy Institute (CAPI), The Almond Board of California, The California Strawberry Commission, Orafti, the Canola and Flax Councils of Canada, Pulse Canada, the Saskatchewan Pulse Growers, and Abbott Laboratories. D. J. A. J. also holds additional grant support from the CIHR, Canadian Foundation for Innovation (CFI), Ontario Research Fund (ORF), and Advanced Foods and Material Network (AFMNet). T. M. S. W. is the President, A. L. J. a Vice-President and Director of Research and L. C. a casual Clinical Research Coordinator at GI Laboratories, Toronto, Canada. A. I. C., A. M., A. J. C., V. H., D. D. W., M. E. Y., M. D. B. and L. A. L. have no declared conflicts of interest related to this paper.
1Sievenpiper, JL, Carleton, AJ, Chatha, S, et al. (2009) Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: systematic review and meta-analysis of experimental trials in humans. Diabetes Care 32, 1930–1937.
2Canadian Diabetes Association Clinical Practice Guidelines Expert Committee (2008) Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 32, S1–S201.
3Hawkins, M, Gabriely, I, Wozniak, R, et al. (2002) Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes. Diabetes 51, 606–614.
4Petersen, KF, Laurent, D, Yu, C, et al. (2001) Stimulating effects of low-dose fructose on insulin-stimulated hepatic glycogen synthesis in humans. Diabetes 50, 1263–1268.
5Moore, MC, Cherrington, AD, Mann, SL, et al. (2000) Acute fructose administration decreases the glycemic response to an oral glucose tolerance test in normal adults. J Clin Endocrinol Metab 85, 4515–4519.
6Moore, MC, Davis, SN, Mann, SL, et al. (2001) Acute fructose administration improves oral glucose tolerance in adults with type 2 diabetes. Diabetes Care 24, 1882–1887.
7Heacock, PM, Hertzler, SR & Wolf, BW (2002) Fructose prefeeding reduces the glycemic response to a high-glycemic index, starchy food in humans. J Nutr 132, 2601–2604.
8Heyland, DK, Novak, F, Drover, JW, et al. (2001) Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 286, 944–953.
10Grigoresco, C, Rizkalla, SW, Halfon, P, et al. (1998) Lack of detectable deleterious effects on metabolic control of daily fructose ingestion for 2 mo in NIDDM patients. Diabetes Care 11, 546–550.
11Blayo, A, Fontveille, AM, Rizkalla, S, et al. (1990) Effets metaboliques de la consommation quotidienne pendant un an de saccharose ou de fructose par des diabetiques (Metabolic effects of a one year daily intake of granulated sucrose or fructose by diabetic patients). Médecine et Nutrition 26, 909–913.
12Vaisman, N, Niv, E & Izkhakov, Y (2006) Catalytic amounts of fructose may improve glucose tolerance in subjects with uncontrolled non-insulin-dependent diabetes. Clin Nutr 25, 617–621.
13Sunehag, AL, Toffolo, G, Treuth, MS, et al. (2002) Effects of dietary macronutrient content on glucose metabolism in children. J Clin Endocrinol Metab 87, 5168–5178.
14Rizkalla, SW, Baigts, F, Fumeron, F, et al. (1986) Comparative effects of several simple carbohydrates on erythrocyte insulin receptors in obese subjects. Pharmacol Biochem Behav 25, 681–688.
16Jenkins, DJ, Srichaikul, K, Kendall, CW, et al. (2011) The relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes. Diabetologia 54, 271–279.
17Sievenpiper, JL, de Souza, RJ, Kendall, CW, et al. (2011) Is fructose a story of mice but not men? J Am Diet Assoc 111, 219–220.
18Peter, A, Stefan, N, Cegan, A, et al. (2011) Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humans. J Clin Endocrinol Metab 96, E1126–E1130.
19Livesey, G & Taylor, R (2008) Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies. Am J Clin Nutr 88, 1419–1437.
20Marriott, BP, Cole, N & Lee, E (2009) National estimates of dietary fructose intake increased from 1977 to 2004 in the united states. J Nutr 139, 1228S–1235S.
21Malik, VS, Popkin, BM, Bray, GA, et al. (2010) Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 121, 1356–1364.
22Rech, ME (1996) Observations on the decay of glycated hemoglobin HbA1c in diabetic patients. Exp Clin Endocrinol Diabetes 104, 102–105.